Publication:
Addition of Fentanyl to Bupivacaine Prolongs Anesthesia and Analgesia in Axillary Brachial Plexus Block

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Abstract

Background and Objectives: To evaluate the analgesic and anesthetic effects of 40 mL bupivacaine 0.25 %, 40 mL bupivacaine 0.25% plus fentanyl 2.5 μg/mL, and 40 mL bupivacaine 0.125% plus fentanyl 2.5 μg/mL for axillary brachial plexus block. Methods: Sixty patients were randomly allocated to 3 groups and received axillary brachial plexus block with 40 mL bupivacaine 0.25% (group B), 40 mL bupivacaine 0.25% with fentanyl 2.5 μg/mL (group BF), or 40 mL bupivacaine 0.125% with fentanyl 2.5 μg/mL (group DBF). The onset times and the duration of sensory and motor blocks, duration of analgesia, hemodynamic parameters, and adverse events were noted. Results: The mean duration of sensory block and analgesia were longer in group BF (10.1 hours and 20.9 hours) than group B (6.9 hours and 11.6 hours) and DBF (5.9 hours and 12.0 hours) (P < 01, P < .001, respectively). The mean duration of motor block was also longer in group BF (10.7 hours) than group B (4.9 hours) (P < .01). Only 2 patients experienced motor block in group DBF. The frequency of successful block was 35% in group DBF (P < .01). Hemodynamic parameters were similar in all groups. In group B, only 1 patient experienced dizziness. Nausea was observed in 1 patient in each fentanyl group. Conclusion: The addition of 100 μg/mL fentanyl to 0.25% bupivacaine almost doubles the duration of analgesia following axillary brachial plexus block when compared with 0.25% bupivacaine alone.

Description

Citation

WoS Q

Q1

Scopus Q

Q1

Source

Regional Anesthesia and Pain Medicine

Volume

26

Issue

5

Start Page

434

End Page

438

Endorsement

Review

Supplemented By

Referenced By